Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

4
PetChem eyes acquisitions to boost specialty business

1h thestar.com.my
KUALA LUMPUR: The chemical manufacturing unit of Petroliam Nasional Bhd (Petronas) is actively looking to acquire companies to expand its specialty chemical business, its chief executive officer said.
RDS.B 5183 RDS.A PECGF XOM RYDBF RDSB RDSA RYDAF

6
Ranks of most valuable companies shifted during bull market

7h nzherald.co.nz
NEW YORK (AP) — The most valuable American companies at the start of the current bull market included an oil company and retail and consumer goods giants, and just one technology company.
BRK.A XOM PCP

3
ConocoPhillips and Venezuela's PDVSA reach $2 billion settlement

7h cnbc
HOUSTON — More than a decade ago, Venezuela seized several oil projects from the American oil company ConocoPhillips without compensation. Now, under pressure after ConocoPhillips carried out its own seizures, the Venezuelans are going to make amends.
XOM NYTAB

58
Why Apple Stock May Fall Victim to the Winner’s Curse

8h investorplace
Apple (NASDAQ:AAPL) recently made stock market history. It beat all the challengers, topping Amazon (NASDAQ:AMZN), Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG), and other potential rivals to the crown. The prize? AAPL stock recently became the first equity in American history to sport a market capitalization of $1 trillion.
IBM GE GEC AMZN XOM GOOGL AAPL GNE GOOG

7
Kinder Morgan: Halfway To A Warren Buffett Company

10h seekingalpha
Warren Buffett has sold his investment in Kinder Morgan, an investment I applauded when he first made it.
BP KMI XOM KMR KMRFZ CVB

3
Sen. Elizabeth Warren's new reform bill would ban members of Congress from owning individual stocks

12h cnbc
Sen. Elizabeth Warren wants to ban members of Congress and the White House staff from owning individual stocks — and replace them with government-managed investment accounts.
XOM

3
Exxon Mobil: Not Near The Ledge

14h seekingalpha
Despite a recent article trying to talk XOM investors off the ledge, XOM is doing fine.
XOM

4
Petronas Chemicals eyeing acquisitions to boost specialty business

16h theedgemarkets
KUALA LUMPUR (Aug 21): The chemical manufacturing unit of Malaysia's state energy firm Petronas is actively looking to acquire companies to expand its specialty chemical business, its chief executive officer said on Tuesday.
RDS.B 5183 RDS.A PECGF XOM RYDBF RDSB RDSA RYDAF

3
UPDATE 4-ConocoPhillips, Venezuela's PDVSA reach $2 bln settlement

2018-08-20 reuters
(Reuters) - U.S. producer ConocoPhillips (COP.N) and Venezuela’s PDVSA have reached a payment agreement on a $2-billion arbitration award, the companies said, suspending a dispute that blocked the state-run firm from exporting oil from most of its key Caribbean facilities.
XOM

9
Chevron Corporation: A Look At The Second Quarter Earnings Results

2018-08-20 seekingalpha
Chevron's second quarter revenues were $42.24 billion, up 22.5% compared to a year ago and up 11.9% sequentially. Chevron posted second quarter earnings of $3.4 billion or $1.78 per diluted share.
RDS.B RDS.A XOM CVX RYDBF RDSB RDSA RYDAF OXY

3
Exxon Stock Is Packed Full of Easy Profits in 2018

2018-08-20 investorplace
Last February, the stock market had a sharp correction from fears of runaway interest rates. Usually a spike in rates causes a crimp on business activity, thereby negatively affecting the corporate P&Ls. In addition to the February market-wide fears, Exxon Mobil (NYSE:XOM) stock had its own reasons to fall over 20% from an earnings event.
XOM

6
BP Plc - A Look At The Second-Quarter Earnings Results

2018-08-20 seekingalpha
Goldman Sachs said: "BP is on the cusp of delivering one of the industry's strongest pipelines of new oil & gas projects."
BLT XOM BHPBF BP BP.A BP.B BP BHP BBL BHP BPAQF BHPLF BPMP

136
Revisiting the Trump Portfolios - The Big Picture

2018-08-20 ritholtz
Betting Against Trump Was a Market-Beater The companies the president disparaged have done much better than those he favored. Bloomberg, January 10, 2018
STZ.B XOM TWX GLSSP TWTR JBK TMUSP TMUS TFG TYT STZ UTX TWC 7203 9984 BA LMT FB TM PYPL SFTBF GS BOE GM SFTBY CLNS GSC NYTAB TOYOF GSJ S RXN PEP CLNY TSLA GJS

3
ExxonMobil (XOM) Executes SPA for PNG LNG Project With BP

2018-08-20 zacks
Per Oil Search Limited, Exxon Mobil Corporation (XOM - Free Report) , co-venturer and operator of PNG LNG project in Papua New Guinea, announced a mid-term LNG sale and purchase agreement (SPA) with BP plc (BP - Free Report) . Per the SPA, about 0.45 million tons of liquefied natural gas per annum (mtpa) will be delivered to BP for the initial three-year period, which will gradually rise to about 0.
OISHF OISHY XOM SSLZY OSH

4
5 Reasons This 6% Yielding Blue Chip Is A Retirement Dream Stock

2018-08-20 seekingalpha
High-yield blue chip income growth stocks have historically been the best performing asset class in history.
ENBBF ENB XOM EBBNF EPD ENB MMP SEP

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 30231G102